| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |